Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Learn more about the possibilities of this page

Chemed Corp. Stock

Price
Target price
?

?

-13.560%
-64.0
-13.560%
€579.64
 
07:34 / Stuttgart Stock Exchange WKN: A0CBF4 / Symbol: CHE / Name: Chemed / Stock / Healthcare Providers & Services / Mid Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Chemed Corp. in the next few years
Wizard

Chemed Corp. Stock

Heavy losses for Chemed Corp. today as the stock fell by -€64.000 (-13.560%).
With 6 Buy predictions and not the single Sell prediction the community is currently very high on Chemed Corp..
With a target price of 579 € there is a positive potential of 41.91% for Chemed Corp. compared to the current price of 408.0 €.
So far the community has only identified positive things for Chemed Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
What does Chemed do?

Pros and Cons of Chemed Corp. in the next few years

Pros
?
S********** s********
?
C******** o* t** e**********
?
B****
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

Performance of Chemed Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Chemed Corp. -13.560% 0.424% -5.200% -6.139% -4.819% - -
Amn Healthcare Svs -2.790% -2.732% -3.784% -61.966% -21.930% -82.885% -54.592%
Ensign Group Inc. 0.760% -0.758% 0.769% 12.931% 3.150% - -
Select Medical Holdings 0.790% -0.787% -5.263% -61.585% -30.000% -44.248% -0.787%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2025-04-29

CHEMED CORP's Q2 2025 financial report indicates a strong financial position with significant revenue growth and healthy profitability. Key findings include:

The overall financial trend appears positive, driven by revenue growth and improving profitability.

This analysis provides a factual assessment of CHEMED CORP's financial health based on the provided Q2 2025 financial report data. Investors should consider these factors when evaluating the company's potential future performance.

Show more

Comments

Prediction Buy
Perf. (%) 1.49%
Target price 546.048
Change
Ends at 30.06.26

Chemed Corporation (NYSE: CHE) had its price target lowered by analysts at Royal Bank Of Canada from $674.00 to $640.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat
Show more

Royal Bank of Canada 
0
Report Share
30.06.25
Prediction Buy
Perf. (%) 1.49%
Target price 554.580
Change
Ends at 30.06.26

Chemed Corporation (NYSE: CHE) had its price target lowered by analysts at Bank of America Corporation from $708.00 to $650.00. They now have a "buy" rating on the stock.
Ratings data for CHE provided by MarketBeat
Show more

Bank of America Co. 
0
Report Share
30.06.25
Prediction Buy
Perf. (%) -4.88%
Target price 593.592
Change
Ends at 28.04.26

Chemed Co. (NYSE: CHE) had its price target raised by analysts at Royal Bank of Canada from $667.00 to $674.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat
Show more

Royal Bank of Canada 
0
Report Share
28.04.25
Show more
Not a member yet? Sign up for free!

News

Chemed To Report Second-Quarter 2025 Earnings July 29, 2025
Chemed To Report Second-Quarter 2025 Earnings July 29, 2025


Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2025, on Tuesday, July 29, 2025, following the close of trading on the

BusinessWire_EN 
0 27.06.25
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend


Stockholders of Chemed Corporation (NYSE: CHE) today elected a slate of nine directors at the Company’s 2025 annual stockholders’ meeting.



Stockholders ratified the continuation of

BusinessWire_EN 
0 19.05.25
Chemed Corporation to Present at the 2025 RBC Global Healthcare Conference
Chemed Corporation to Present at the 2025 RBC Global Healthcare Conference


Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Global Healthcare Conference on Wednesday, May 21, 2025, at approximately 9:30 a.m. (ET) at The

BusinessWire_EN 
0 14.05.25